ExodusPoint Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
ExodusPoint Capital Management's CRL Position: Q3 2026 in Review
ExodusPoint Capital Management opened a new position in Charles River Laboratories (CRL) in Q3 2026: 65,230 shares worth $19.2M. The stake represents 0.1% of the portfolio and ranks #203 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in CRL as recently as Q1 2026.
ExodusPoint Capital Management first reported a position in CRL in Q3 2019 and has held it in 14 quarters since. The position peaked at $27.9M in Q1 2021. 646 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- ExodusPoint Capital Management held 65,230 shares of Charles River Laboratories worth $19.2M as of Q3 2026.
- Charles River Laboratories was a new ExodusPoint Capital Management position in Q3 2026.
- Charles River Laboratories made up 0.1% of ExodusPoint Capital Management's portfolio in Q3 2026, its #203 holding.
- ExodusPoint Capital Management first reported a position in Charles River Laboratories in Q3 2019 and has held it in 14 quarters since.
- ExodusPoint Capital Management's Charles River Laboratories position peaked at $27.9M in Q1 2021.
- 646 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.